Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
Joanna J. Regan, Megan Wallace(Centers for Disease Control and Prevention), Danielle Moulia(Centers for Disease Control and Prevention), Oliver Brooks, Ruth Link‐Gelles(Centers for Disease Control and Prevention), Sharon Saydah(Centers for Disease Control and Prevention), Natalie J. Thornburg(Oak Ridge Associated Universities), Hannah G. Rosenblum(National Center for Immunization and Respiratory Diseases), Katherine E. Fleming-Dutra(Centers for Disease Control and Prevention), Georgina Peacock(National Center for Immunization and Respiratory Diseases), Sarah Meyer, Evelyn Twentyman(Synaptic Research (United States)), Monica Godfrey, Grace M. Lee, Fiona P. Havers(Centers for Disease Control and Prevention), H. Keipp Talbot(Marshfield Clinic), Beth P. Bell(Centers for Disease Control and Prevention), Melisa M. Shah(National Center for Immunization and Respiratory Diseases), Morgan Najdowski, Josephine Mak, Barbara E. Mahon(Boston University), Matthew F. Daley(Kaiser Permanente)
Cited by 142
Related Papers
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.4k
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
|Emerging infectious diseases|2020|628
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021
|MMWR Morbidity and Mortality Weekly Report|2021|611
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602